- Home
- POLA vs OGEN Comparison
POLA vs OGEN Comparison
Compare POLA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- OGEN
- Stock Information
- Founded
- POLA 1979
- OGEN 1996
- Country
- POLA United States
- OGEN United States
- Employees
- POLA N/A
- OGEN N/A
- Industry
- POLA Industrial Machinery/Components
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- OGEN Health Care
- Exchange
- POLA Nasdaq
- OGEN Nasdaq
- Market Cap
- POLA 4.3M
- OGEN 2.5M
- IPO Year
- POLA 2016
- OGEN N/A
- Fundamental
- Price
- POLA $1.86
- OGEN $1.53
- Analyst Decision
- POLA
- OGEN
- Analyst Count
- POLA 0
- OGEN 0
- Target Price
- POLA N/A
- OGEN N/A
- AVG Volume (30 Days)
- POLA 274.8K
- OGEN 1.1M
- Earning Date
- POLA 08-13-2025
- OGEN 08-08-2025
- Dividend Yield
- POLA N/A
- OGEN N/A
- EPS Growth
- POLA N/A
- OGEN N/A
- EPS
- POLA N/A
- OGEN N/A
- Revenue
- POLA $13,918,000.00
- OGEN N/A
- Revenue This Year
- POLA N/A
- OGEN N/A
- Revenue Next Year
- POLA N/A
- OGEN N/A
- P/E Ratio
- POLA N/A
- OGEN N/A
- Revenue Growth
- POLA 8.08
- OGEN N/A
- 52 Week Low
- POLA $1.53
- OGEN $1.35
- 52 Week High
- POLA $4.90
- OGEN $75.60
- Technical
- Relative Strength Index (RSI)
- POLA 57.07
- OGEN 27.36
- Support Level
- POLA $1.53
- OGEN $1.35
- Resistance Level
- POLA $2.75
- OGEN $4.19
- Average True Range (ATR)
- POLA 0.14
- OGEN 0.43
- MACD
- POLA 0.03
- OGEN -0.22
- Stochastic Oscillator
- POLA 27.05
- OGEN 5.14
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.